|
|
|
| Our products |
|
|
 |
|
|
|
|
|
|
|
|
| Other information |
|
|
|
Rabbit anti-Human Progesterone Receptor (Clone : SP2) - IMG-80334 |
| Imprimer |
| | | Rabbit Monoclonal Antibody to Progesterone Receptor (Clone SP2) | | Catalog No | : | IMG-80334 | | Contents | : | This antibody is supplied as tissue culture supernatant containing 0.05% sodium azide as preservative. | | Isotype | : | Rabbit IgG | | Clone | : | SP2 | | Species React | : | Human | | Host | : | Rabbit | | | Application IHC (paraffin): 1:100 Storage Store the antibody at 4-8°C. Recommended Positive Control : Breast Carcinoma |
| Background Principal Names: Progesterone receptor Official Gene Symbol: PGR Gene ID: 5241 (Human) Gene Map Locus: 11q22-q23 (Human) The human progesterone receptor (hPR) belongs to the superfamily of nuclear receptors (including those for steroid and thyroid hormones, and retinoids) whose members coordinate morphogenesis and homeostasis in response to the binding of their ligands. These receptors act as transcriptional factors that regulate gene expression positively or negatively by interacting with cognate DNA sequences. It exists as two functionally distinct isoforms, PR-A and PR-B. The proteins are identical except for an additional 164 residues located at the N terminus of PR-B. whereas both isoforms appear to have similar DNA binding affinities, PR-B in fact has a greatly increased intrinsic binding affinity and cooperative binding ability relative to PR-A. The differences map to a unique AF3 in the B-upstream segment (BUS), at the far N terminus of PR-B, which is missing in PR-A. It maps to 11q22-q23 region of human chromosome. |
Antigen Recombinant protein encoding human progesterone receptor 412-526 aa.
| Application Notes We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. Formalin fixed paraffin embedded tissue sections require high temperature antigen unmasking with 10 mM citrate buffer, pH 6.0 prior to immunostaining. Specificity: The progesterone receptor (PgR) is an estrogen-regulated protein. It has been proposed that expression of PgR determination indicates a responsive estrogen receptor (ER) pathway, and therefore, may predict likely response to endocrine therapy in human breast cancer. A number of studies have shown that PgR determination provides supplementary information to ER, both in predicting response to endocrine therapy and estimating survival. PgR has proved superior to ER as a prognostic indicator in some studies. This antibody crossreacts with Human. Cellular Localization: Nuclear. | | | | | | | Reference 1. Cano et al. Diag Cytopathol 29: 207, 2003 2. Connaghan et al. Proc Natl Acad Sci U S A 104: 2187, 2007. 3. Tung et al. Mol Endocrinol 20: 2656, 2006. 4. Kastner et al. EMBO J 9: 1603, 1990. | | | | |
| |